• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过DNA初免和蛋白加强免疫提高编码ESAT6的结核DNA疫苗的免疫原性。

Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting.

作者信息

Wang Qing-Min, Sun Shu-Han, Hu Zhen-Lin, Yin Ming, Xiao Cun-Jie, Zhang Jian-Cheng

机构信息

Department of Medical Genetics, The Second Military Medical University, Xiang'Yin Road 800, Shanghai 200433, China.

出版信息

Vaccine. 2004 Sep 9;22(27-28):3622-7. doi: 10.1016/j.vaccine.2004.03.029.

DOI:10.1016/j.vaccine.2004.03.029
PMID:15315841
Abstract

The study evaluated the immune response elicited by a DNA vaccine encoding ESAT6 protein of Mycobacterium tuberculosis by DNA prime-protein boost protocol. BALB/c mice were respectively vaccinated with plasmid DNA encoding ESAT6 protein, with ESAT6 protein in IFA adjuvant, or a combined DNA prime-protein boost regimen. While DNA immunization induced Th1-polarized immune response, protein-in-adjuvant vaccination elicited a Th2-dominant response. When animals were primed with DNA and boost with protein, both antibodies and Th-cell proliferative response were significantly enhanced. Moreover, production of Th1-type cytokine (IFN-gamma) was increased significantly by DNA priming-protein boosting. This protocol also resulted in an increased relative ratio of IgG2a to IgG1 and the cytotoxicity of T cells. Thus, this study demonstrated that the formation of ESAT6 DNA prime-protein boost inoculation could improved antigen-specific cellular immune responses, which are important for protection against TB infection.

摘要

该研究通过DNA初免-蛋白加强方案评估了编码结核分枝杆菌ESAT6蛋白的DNA疫苗引发的免疫反应。将BALB/c小鼠分别用编码ESAT6蛋白的质粒DNA、含ESAT6蛋白的IFA佐剂或联合DNA初免-蛋白加强方案进行免疫接种。虽然DNA免疫诱导了Th1极化的免疫反应,但佐剂蛋白疫苗接种引发了以Th2为主的反应。当用DNA进行初免并用蛋白进行加强时,抗体和Th细胞增殖反应均显著增强。此外,DNA初免-蛋白加强显著增加了Th1型细胞因子(IFN-γ)的产生。该方案还导致IgG2a与IgG1的相对比例增加以及T细胞的细胞毒性增加。因此,本研究表明,ESAT6 DNA初免-蛋白加强接种的形成可改善抗原特异性细胞免疫反应,这对于预防结核感染很重要。

相似文献

1
Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting.通过DNA初免和蛋白加强免疫提高编码ESAT6的结核DNA疫苗的免疫原性。
Vaccine. 2004 Sep 9;22(27-28):3622-7. doi: 10.1016/j.vaccine.2004.03.029.
2
Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.结核分枝杆菌早期分泌抗原ESAT-6与Flt3配体的重组DNA疫苗增强了小鼠的细胞介导免疫。
Vaccine. 2008 Aug 18;26(35):4519-25. doi: 10.1016/j.vaccine.2008.06.044. Epub 2008 Jul 1.
3
Improved immunogenicity and protective efficacy of a tuberculosis DNA vaccine encoding Ag85 by protein boosting.通过蛋白加强免疫提高编码Ag85的结核DNA疫苗的免疫原性和保护效力。
Infect Immun. 2001 May;69(5):3041-7. doi: 10.1128/IAI.69.5.3041-3047.2001.
4
Improved cellular immune response elicited by a ubiquitin-fused ESAT-6 DNA vaccine against Mycobacterium tuberculosis.泛素融合的ESAT-6 DNA疫苗引发的针对结核分枝杆菌的细胞免疫反应增强。
Microbiol Immunol. 2009 Jul;53(7):384-90. doi: 10.1111/j.1348-0421.2009.00138.x.
5
Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.与聚乳酸-乙醇酸共聚物-聚乙烯亚胺(PLGA-PEI)纳米颗粒相关的编码结核分枝杆菌潜伏抗原Rv1733c的DNA经肺部递送,可增强小鼠DNA初免/蛋白加强免疫方案中的T细胞反应。
Vaccine. 2009 Jun 19;27(30):4010-7. doi: 10.1016/j.vaccine.2009.04.033. Epub 2009 May 3.
6
Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv.用编码结核分枝杆菌分支菌酸转移酶Ag85A的质粒DNA进行启动而非加强免疫,可增加接种卡介苗的小鼠在经静脉低剂量接种结核分枝杆菌H37Rv后的存活时间。
Vaccine. 2006 Apr 12;24(16):3353-64. doi: 10.1016/j.vaccine.2005.12.066. Epub 2006 Feb 6.
7
Immune responses induced by heterologous boosting of recombinant bacillus Calmette-Guerin with Ag85B-ESAT6 fusion protein in levamisole-based adjuvant.在左旋咪唑佐剂中用 Ag85B-ESAT6 融合蛋白异源增强重组卡介苗引起的免疫应答。
Immunol Invest. 2012;41(4):412-28. doi: 10.3109/08820139.2012.658940. Epub 2012 Feb 23.
8
Immunogenicity and protective efficacy of a tuberculosis DNA vaccine expressing a fusion protein of Ag85B-Esat6-HspX in mice.结核分枝杆菌 Ag85B-Esat6-HspX 融合蛋白 DNA 疫苗免疫小鼠的免疫原性和保护效力。
Vaccine. 2012 Mar 23;30(14):2490-7. doi: 10.1016/j.vaccine.2011.06.029. Epub 2011 Jun 23.
9
Therapeutic efficacy of a tuberculosis DNA vaccine encoding heat shock protein 65 of Mycobacterium tuberculosis and the human interleukin 2 fusion gene.编码结核分枝杆菌热休克蛋白65与人白细胞介素2融合基因的结核DNA疫苗的治疗效果
Tuberculosis (Edinb). 2009 Jan;89(1):54-61. doi: 10.1016/j.tube.2008.09.005. Epub 2008 Dec 3.
10
Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant.用Ribi佐剂调节小鼠对结核分枝杆菌PE和PPE蛋白家族重组抗原的免疫反应。
Vaccine. 2007 Oct 10;25(41):7168-76. doi: 10.1016/j.vaccine.2007.07.026. Epub 2007 Aug 2.

引用本文的文献

1
DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies.DNA 和 RNA 结核病疫苗:人体和动物研究的范围综述。
Front Immunol. 2024 Oct 3;15:1457327. doi: 10.3389/fimmu.2024.1457327. eCollection 2024.
2
High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity.对 16 种 SARS-CoV-2 疫苗组合的高维分析揭示了与免疫原性相关的淋巴细胞特征。
Nat Immunol. 2023 Jun;24(6):941-954. doi: 10.1038/s41590-023-01499-w. Epub 2023 Apr 24.
3
Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape.
纳米材料在结核病 DNA 疫苗传递中的应用:历史回顾与现状分析。
Drug Deliv. 2022 Dec;29(1):2912-2924. doi: 10.1080/10717544.2022.2120565.
4
Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review.新冠病毒疫苗混合接种(异源加强免疫)综述
Infect Dis Rep. 2022 Jul 20;14(4):537-546. doi: 10.3390/idr14040057.
5
Exploring heterologous prime-boost vaccination approaches to enhance influenza control in pigs.探索异源初免-加强免疫接种方法以增强猪流感控制。
Vet Res. 2020 Jul 9;51(1):89. doi: 10.1186/s13567-020-00810-z.
6
Heterologous vaccination targeting prostatic acid phosphatase (PAP) using DNA and vaccines elicits superior anti-tumor immunity dependent on CD4+ T cells elicited by DNA priming.使用DNA和疫苗针对前列腺酸性磷酸酶(PAP)进行异源疫苗接种可引发卓越的抗肿瘤免疫,这种免疫依赖于由DNA启动引发的CD4 + T细胞。
Oncoimmunology. 2018 May 7;7(8):e1456603. doi: 10.1080/2162402X.2018.1456603. eCollection 2018.
7
Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.克氏锥虫 80 kDa 脯氨酰寡肽酶(Tc80)作为一种新型的恰加斯病疫苗免疫原。
PLoS Negl Trop Dis. 2018 Mar 30;12(3):e0006384. doi: 10.1371/journal.pntd.0006384. eCollection 2018 Mar.
8
Prime-boost vaccination targeting prostatic acid phosphatase (PAP) in patients with metastatic castration-resistant prostate cancer (mCRPC) using Sipuleucel-T and a DNA vaccine.针对转移性去势抵抗性前列腺癌(mCRPC)患者的前列腺酸性磷酸酶(PAP)的初免-加强免疫接种,使用 Sipuleucel-T 和 DNA 疫苗。
J Immunother Cancer. 2018 Mar 13;6(1):21. doi: 10.1186/s40425-018-0333-y.
9
Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model.腺病毒初免和杆状病毒加强的异源免疫在小鼠模型中实现了对疟原虫孢子虫挑战的无菌保护。
Sci Rep. 2018 Mar 1;8(1):3896. doi: 10.1038/s41598-018-21369-y.
10
Ag85A/ESAT-6 chimeric DNA vaccine induces an adverse response in tuberculosis-infected mice.Ag85A/ESAT-6嵌合DNA疫苗在结核感染小鼠中引发不良反应。
Mol Med Rep. 2016 Aug;14(2):1146-52. doi: 10.3892/mmr.2016.5364. Epub 2016 Jun 3.